Ocular Therapeutix (OCUL) Operating Income (2016 - 2025)
Historic Operating Income for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to -$69.8 million.
- Ocular Therapeutix's Operating Income fell 3793.1% to -$69.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$270.0 million, marking a year-over-year decrease of 5718.62%. This contributed to the annual value of -$270.0 million for FY2025, which is 5718.68% down from last year.
- As of Q4 2025, Ocular Therapeutix's Operating Income stood at -$69.8 million, which was down 3793.1% from -$68.7 million recorded in Q3 2025.
- In the past 5 years, Ocular Therapeutix's Operating Income registered a high of -$17.8 million during Q1 2022, and its lowest value of -$69.8 million during Q4 2025.
- Moreover, its 5-year median value for Operating Income was -$21.1 million (2022), whereas its average is -$34.0 million.
- As far as peak fluctuations go, Ocular Therapeutix's Operating Income soared by 1184.0% in 2022, and later tumbled by 15224.94% in 2024.
- Ocular Therapeutix's Operating Income (Quarter) stood at -$18.0 million in 2021, then dropped by 7.27% to -$19.4 million in 2022, then dropped by 3.56% to -$20.0 million in 2023, then tumbled by 152.25% to -$50.6 million in 2024, then tumbled by 37.93% to -$69.8 million in 2025.
- Its Operating Income stands at -$69.8 million for Q4 2025, versus -$68.7 million for Q3 2025 and -$67.6 million for Q2 2025.